Continuous glucose monitors (CGMs) are wearable devices that track your blood sugar in real time, helping people with type 1 and type 2 diabetes prevent dangerous glucose swings and make smarter decisions about food, exercise, and insulin. In 2026, the CGM landscape has shifted dramatically with smaller sensors, extended wear times reaching up to 365 days, and new over-the-counter options that don't require a prescription. These advances are making diabetes management more convenient and accurate than ever before. What Makes Today's CGMs So Different From Previous Versions? The evolution of CGM technology over the past few years has been remarkable. The newest devices are smaller, more accurate, and easier to use than their predecessors. For example, the Dexcom G7, released in early 2023, is 60% smaller than the G6 model it replaced, with a more circular shape that's less intrusive on the skin. Beyond size, the G7 warms up in just 30 minutes compared to the G6's two-hour wait time, and it now offers 15.5 days of continuous wear, including a 12-hour grace period. Accuracy is measured using a metric called MARD (Mean Absolute Relative Difference), which shows how closely a CGM's readings match actual blood glucose values. The smaller the MARD score, the more accurate the device. Most modern systems have MARD scores between 9% and 14%, but the latest generation performs even better. The Dexcom G7 achieves an 8.2% MARD for adults and 8.1% for children, while the Abbott FreeStyle Libre 3 Plus matches that performance at approximately 8.2%. How Do You Choose the Right CGM for Your Needs? With multiple options now available, selecting a CGM depends on your lifestyle, budget, and specific diabetes management goals. Here are the key factors to consider when evaluating your options: - Wear Time and Convenience: The Dexcom G7 and Abbott FreeStyle Libre 3 Plus both offer 15 days of wear, while the revolutionary Eversense 365 provides a full year of continuous monitoring with just one implanted sensor, eliminating the need for frequent replacements. - Sensor Size and Discretion: The Abbott FreeStyle Libre 3 Plus is the world's smallest and thinnest CGM sensor, roughly the size of two stacked pennies, making it ideal if you prioritize discretion and comfort during daily activities. - Warm-Up Time: If you want immediate glucose readings without waiting, the Abbott FreeStyle Libre 3 Plus has zero warm-up time, while the Dexcom G7 requires 30 minutes and older models may take up to two hours. - Pump Compatibility: Different CGMs integrate with different insulin pump systems; the Dexcom G7 works with Tandem Mobi, t:slim X2, and Omnipod 5, while the Abbott FreeStyle Libre 3 Plus is compatible with Tandem, Omnipod 5, iLet Bionic Pancreas, and Twiist systems. - Over-the-Counter Access: For those without insurance coverage or prescriptions, Dexcom's Stelo Glucose Biosensor System is now available over-the-counter for type 2 diabetes management, along with Abbott's Lingo for metabolic health. What Are the Real-World Benefits of Using a CGM? According to the American Diabetes Association (ADA), individuals wearing CGMs experience significant improvements in their diabetes management. People using these devices achieve higher time in range (TIR), typically maintaining blood glucose levels between 70 and 180 mg/dL, which is the target zone for most people with diabetes. Beyond glucose control, CGM users report improved daily energy levels, better sleep quality, fewer dangerous low blood sugar episodes, and reduced risk of long-term diabetes complications. The psychological benefit is equally important. Knowing your glucose trends in real time reduces anxiety about blood sugar swings and empowers you to make immediate adjustments to your diet or activity level. For people with type 1 diabetes, this real-time feedback can be life-changing, as it helps prevent both hypoglycemia (dangerously low blood sugar) and hyperglycemia (dangerously high blood sugar). Which CGM Should You Actually Choose? The top CGM options for 2026 each serve different needs. The Dexcom G7 remains the best overall choice for most people due to its combination of high accuracy, fast warm-up time, small size, and excellent smartphone and smartwatch integration. Its one-step application process is simpler than older models, and it's widely compatible with insulin pumps. For those prioritizing the smallest possible sensor, the Abbott FreeStyle Libre 3 Plus delivers with its penny-sized design and zero warm-up time. It's also highly affordable and works with multiple automated insulin delivery systems. However, it can only be worn on the back of the arm, not the stomach like some competitors. For people seeking the ultimate in convenience, the Eversense 365 represents a breakthrough. As the world's first one-year implantable CGM, it requires only a single warm-up period annually and eliminates the burden of changing sensors every 10 to 15 days. The removable transmitter can be taken off without wasting the sensor or triggering a new warm-up period, and it includes on-body vibration alerts that notify you even when your phone is out of sight. With an 8.8% MARD score, it maintains high accuracy throughout the year. Most health insurance plans now cover CGMs, though you'll typically need a prescription from your healthcare provider. The recent FDA approvals of over-the-counter options like Dexcom Stelo have expanded access for people with type 2 diabetes who may not have had coverage previously. Before choosing a CGM, discuss your options with your healthcare team. They can help you weigh factors like your insurance coverage, pump compatibility, lifestyle needs, and personal preferences. The right CGM is the one you'll actually use consistently, so comfort, ease of use, and integration with your daily routine matter just as much as raw accuracy numbers.
